The DOI matches its Crossref record; 304 of the 305 references it cites were found in a registry or an index.
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
Open accessAbstract
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report focuses primarily on the revised and novel parts of the document. The most significant changes include: (1) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (2) for each of the groups A to D, escalation strategies for pharmacologic treatments are proposed; (3) the concept of deescalation of therapy is introduced in the treatment assessment scheme; (4) nonpharmacologic therapies are comprehensively presented; and (5) the importance of comorbid conditions in managing chronic obstructive pulmonary disease is reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The current treatment strategy for COPD includes inhaled corticosteroids, anticholinergics, and β2-agonists, which have been primarily effective in controlling the symptoms but do not cure the underlying disease.184”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [184]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Celli, B. R., MacNee, W., Agustí, A. G. N., Anzueto, A. R., Berg, B., Buist, A. S., Calverley, P. M., Chavannes, N. H., Dillard, T. A., Fahy, B. F., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,405
Self-citationCelli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
Self-citationSpruit, M. A., Singh, S. J., Garvey, C., ZuWallack, R., Nici, L., Rochester, C., Hill, K., Holland, A. E., Lareau, S. C., Man, W. D.-C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1634st · Cited by 3,938
Self-citationSalmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
CALVERLEY, P. M. A., Anderson, J. A., Celli, B. R., Ferguson, G. T., Jenkins, C. R., Jones, P., Yates, J., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,234
Self-citationJones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.6.1321 · Cited by 3,035
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A. R., Locantore, N., Müllerová, H., Tal‐Singer, R., Miller, B. E., Lomas, D. A., Agustí, A. G. N., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,983
Self-citationBestall, J. C., Paul, E. A., Garrod, R., Garnham, R., Jones, P. W., & Wedzicha, J. A. (1999) · Thorax · doi:10.1136/thx.54.7.581 · Cited by 2,927
Self-citationAntibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
Anthonisen, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,474
Buist, A. S., McBurnie, M. A., Vollmer, W. M., Gillespie, S., Burney, P., Mannino, D. M., Menezes, A. M., Sullivan, S. D., Lee, T. A., Weiss, K. B., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61377-4 · Cited by 2,364
Flagged first, then by citations
1 of the 305 references couldn’t be matched to a known paper.
Research works printed but not linked: 34
- Medical Research Council Committee on the Aetiology of Chronic Bronchitis, 1965, Definition and classification of chronic bronchitis for clinical and epidemiological purposes: a report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis, Lancet, 1, 775
- Fletcher, 1960, Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score), BMJ, 2, 1662
- National Institute for Health and Care Excellence, 2016, Multimorbidity: clinical assessment and management, in press
- 1997, Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting, Bull World Health Organ, 75, 397
- van Eerd, 2016, Smoking cessation for people with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD010744
- van der Meer, 2003, Smoking cessation for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002999
- McNeill, 2015, E-cigarettes: an evidence update
- McRobbie, 2014, Electronic cigarettes for smoking cessation and reduction, Cochrane Database Syst Rev, 12, CD010216
- Cahill, 2013, Pharmacological interventions for smoking cessation: an overview and network meta-analysis, Cochrane Database Syst Rev, 5, CD009329
- Stead, 2013, Physician advice for smoking cessation, Cochrane Database Syst Rev, 5, CD000165
- Stead, 2016, Combined pharmacotherapy and behavioural interventions for smoking cessation, Cochrane Database Syst Rev, 3, CD008286
- Poole, 2006, Influenza vaccine for patients with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002733
- Wongsurakiat, 2003, Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients, J Med Assoc Thai, 86, 497
- Fiore, 2009, Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009, MMWR Recomm Rep, 58, 1
- Appleton, 2006, Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD006101
- Karner, 2014, Tiotropium versus placebo for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 7, CD009285
- Ram, 2002, Oral theophylline for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD003902
- Nannini, 2012, Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 9, CD006829
- Nannini, 2013, Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 8, CD006826
- Yang, 2012, Inhaled corticosteroids for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 7, CD002991
- Chong, 2013, Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 11, CD002309
- Poole, 2015, Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD001287
- Puhan, 2011, Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD005305
- Kruis, 2013, Integrated disease management interventions for patients with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 10, CD009437
- Halpin, 2009, Palliative and end-of-life care for patients with respiratory diseases, Eur Respir Monograph, 43, 327
- Cranston, 2005, Domiciliary oxygen for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD001744
- Barr, 2005, Inhaled tiotropium for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002876
- Karner, 2012, Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 4, CD008989
- Tomczyk, 2014, Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Morb Mortal Wkly Rep, 63, 822
- Tiong, 2006, Lung volume reduction surgery for diffuse emphysema, Cochrane Database Syst Rev, CD001001
- Vollenweider, 2012, Antibiotics for exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 12, CD010257
- Ram, 2006, Antibiotics for exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD004403
- Schuetz, 2012, Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections, Cochrane Database Syst Rev, CD007498
- Bradley, 1985, Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome, Am Rev Respir Dis, 131, 835
Cited by
Sorted by citations
Singh, D., Agustí, A. G. N., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Criner, G. J., Frith, P. A., Halpin, D. M. G., Han, M. K., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.00164-2019 · Cited by 1,994
Self-citationWang, C., Xu, J., Yang, L., Xu, Y., Zhang, X., Bai, C., Kang, J., Ran, P., Shen, H., Wen, F., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30841-9 · Cited by 1,707
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
Lipson, D. A., Barnhart, F., Brealey, N., Brooks, J., Criner, G. J., Day, N. C., Dransfield, M. T., Halpin, D. M. G., Han, M. K., JONES, C. E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1713901 · Cited by 1,257
Self-citationPrevalence, risk factors, and management of asthma in China: a national cross-sectional study
Huang, K., Yang, T., Xu, J., Yang, L., Zhao, J., Zhang, X., Bai, C., Kang, J., Ran, P., Shen, H., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31147-x · Cited by 755
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645
Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease
Agustí, A. G. N., & Hogg, J. C. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1900475 · Cited by 583
Self-citationDefinition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision
Celli, B. R., Fabbri, L. M., Criner, G. J., Martínez, F. J., Mannino, D. M., Vogelmeier, C. F., de, M. M., Papi, A. A., Sin, D. D., Han, M. K., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202204-0671pp · Cited by 586
Self-citationYang, I. A., Jenkins, C. R., & Salvi, S. S. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00506-3 · Cited by 573
Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease
Celli, B. R., & Wedzicha, J. A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1900500 · Cited by 501
Self-citationBrazilian guidelines for the clinical management of paracoccidioidomycosis
Shikanai‐Yasuda, M. A., Mendes, R. P., Colombo, A. L., Queiroz‐Telles, F., Kono, A., Paniago, A. M. M., Nathan, A., Francesconi-do-Valle, A. C., Bagagli, E., Benard, G., et al. (2017) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0230-2017 · Cited by 459
COPD Guidelines: A Review of the 2018 GOLD Report
Mirza, S., Clay, R., Koslow, M., & Scanlon, P. D. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.05.026 · Cited by 456
Yao, R.-Q., Ren, C., Xia, Z.-F., & Yao, Y.-M. (2021) · Autophagy · doi:10.1080/15548627.2020.1725377 · Cited by 441
Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection
Huang, D. T., Yealy, D. M., Filbin, M. R., Brown, A., Chang, C. H., Doi, Y., Donnino, M. W., Fine, J. A., Fine, M. J., Fischer, M. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1802670 · Cited by 437
Ritchie, A. I., & Wedzicha, J. A. (2020) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2020.06.007 · Cited by 403
Self-citationERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure
Oczkowski, S. J. W., Ergan, B., Bos, L. D. J., Chatwin, M., Ferrer, M., Gregoretti, C., Heunks, L. M. A., Frat, J., Longhini, F., Nava, S., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.01574-2021 · Cited by 429
Wang, M., Pistenmaa, C. L., Madrigano, J., Hoffman, E. A., Angelini, E. D., Yang, J., Laine, A. F., Vetterli, T., Kinney, P. L., Sampson, P. D., et al. (2019) · JAMA · doi:10.1001/jama.2019.10255 · Cited by 404
Sakornsakolpat, P., Prokopenko, D., Lamontagne, M., Reeve, N. F., Guyatt, A. L., Jackson, V. E., Shrine, N. R. G., Qiao, D., Bartz, T. M., Kim, D. K., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0342-2 · Cited by 377
Self-citationChalmers, J. D., Chang, A. B., Chotirmall, S. H., Dhar, R., & McShane, P. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0042-3 · Cited by 366
MacLeod, M. A., Papi, A. A., Contoli, M., Beghé, B., Celli, B. R., Wedzicha, J. A., & Fabbri, L. M. (2021) · Respirology · doi:10.1111/resp.14041 · Cited by 392
Self-citationBenralizumab for the Prevention of COPD Exacerbations
Criner, G. J., Celli, B. R., Brightling, C. E., Agustí, A. G. N., Papi, A. A., Singh, D., Sin, D. D., Vogelmeier, C. F., Sciurba, F. C., Bafadhel, M., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1905248 · Cited by 355
Self-citationCharacterization of the “Frequent Exacerbator Phenotype” in Bronchiectasis
Chalmers, J. D., Aliberti, S., Filonenko, A., Shteinberg, M., Goeminne, P. C., Hill, A. T., Fardon, T. C., Obradović, D., Gerlinger, C., Sotgiu, G., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201711-2202oc · Cited by 352
Ebeling, P. R., Nguyen, H. H., Aleksova, J., Vincent, A. J., Wong, P., & Milat, F. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab028 · Cited by 368
Underdiagnosis and Overdiagnosis of Chronic Obstructive Pulmonary Disease
Diab, N., Gershon, A. S., Sin, D. D., Tan, W. C., Bourbeau, J., Boulet, L., & Aaron, S. D. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201804-0621ci · Cited by 325
Self-citationInflammatory endotypes in COPD
Barnes, P. J. (2019) · Allergy · doi:10.1111/all.13760 · Cited by 318
Self-citationBelgrave, D. C. M., Granell, R., Turner, S., Curtin, J. A., Buchan, I. E., Souëf, P. N. L., Simpson, A., Henderson, A. J., & Čustović, A. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30099-7 · Cited by 328
The Role of Macrophages in the Development of Acute and Chronic Inflammatory Lung Diseases
Lee, J., Chun, W., Lee, H. J., Min, J., Kim, S., Seo, J.-Y., Ahn, K., & Oh, S. (2021) · Cells · doi:10.3390/cells10040897 · Cited by 311
At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease
Martínez, F. J., Han, M. K., Allinson, J. P., Barr, R. G., Boucher, R. C., Calverley, P. M. A., Celli, B. R., Christenson, S. A., Crystal, R. G., Fagerås, M., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201710-2028pp · Cited by 290
Self-citationYun, J. H., Lamb, A. E., Chase, R., Singh, D., Parker, M. M., Saferali, A., Vestbo, J., Tal‐Singer, R., Castaldi, P. J., Silverman, E. K., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.04.010 · Cited by 251
Self-citationKirby, M., Tanabe, N., Tan, W. C., Zhou, G., Obeidat, M., Hague, C. J., Leipsic, J. A., Bourbeau, J., Sin, D. D., Hogg, J. C., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201704-0692oc · Cited by 239
Self-citationRabe, K. F., Celli, B. R., Wechsler, M. E., Abdulai, R. M., Luo, X., Boomsma, M. M., Staudinger, H. W., Horowitz, J. E., Baras, A., Ferreira, M. A. R., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00167-3 · Cited by 240
Self-citationLiu, Y.-H., Chen, Y., Wang, Q.-H., Wang, L.-R., Jiang, L., Yang, Y., Chen, X., Li, Y., Cen, Y., Xu, C., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.0461 · Cited by 225
Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality
Bhatt, S. P., Balte, P., Schwartz, J. E., Cassano, P. A., Couper, D. J., Jacobs, D. R., Kalhan, R., O’Connor, G. T., Yende, S. P., Sanders, J. L., et al. (2019) · JAMA · doi:10.1001/jama.2019.7233 · Cited by 212
Association of Dysanapsis With Chronic Obstructive Pulmonary Disease Among Older Adults
Smith, B. M., Kirby, M., Hoffman, E. A., Kronmal, R. A., Aaron, S. D., Allen, N. B., Bertoni, A. G., Coxson, H. O., Cooper, C., Couper, D. J., et al. (2020) · JAMA · doi:10.1001/jama.2020.6918 · Cited by 201
Self-citationCalverley, P. M. A., Anzueto, A., Carter, K., Grönke, L., Hallmann, C., Jenkins, C. R., Wedzicha, J. A., & Rabe, K. F. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30102-4 · Cited by 192
Self-citationChronic Obstructive Pulmonary Disease Biomarkers and Their Interpretation
Stockley, R. A., Halpin, D. M. G., Celli, B. R., & Singh, D. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201810-1860so · Cited by 193
Self-citationBigna, J. J., Kenne, A. M., Asangbeh, S. L., & Sibetcheu, A. T. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30451-5 · Cited by 182
Metoprolol for the Prevention of Acute Exacerbations of COPD
Dransfield, M. T., Voelker, H. T., Bhatt, S. P., BRENNER, K. R., Casaburi, R. H., Come, C. E., Cooper, J. A. D., Criner, G. J., Curtis, J. L., Han, M. K., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908142 · Cited by 186
Self-citationMesoporous silica nanoparticles for pulmonary drug delivery
García‐Fernández, A., Sancenón, F., & Martínez‐Máñez, R. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113953 · Cited by 183
Cadmium in tobacco smokers: a neglected link to lung disease?
Ganguly, K., Levänen, B., Palmberg, L., Åkesson, A., & Lindén, A. (2018) · European Respiratory Review · doi:10.1183/16000617.0122-2017 · Cited by 182
COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease
Lowe, K., Regan, E. A., Anzueto, A., Austin, E. E., Austin, J. H. M., Beaty, T. H., Benos, P. V., Benway, C. J., Bhatt, S. P., Bleecker, E. R., et al. (2019) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.6.5.2019.0149 · Cited by 182
Self-citationChan, S. M. H., Selemidis, S., Bozinovski, S., & Vlahos, R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.013 · Cited by 186
Oelsner, E. C., Balte, P., Bhatt, S. P., Cassano, P. A., Couper, D. J., Folsom, A. R., Freedman, N. D., Jacobs, D. R., Kalhan, R., Mathew, A. R., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30276-0 · Cited by 182
Inhibition of LTβR signalling activates WNT-induced regeneration in lung
Conlon, T. M., John-Schuster, G., Heide, D., Pfister, D. R., Lehmann, M., Hu, Y., Ertüz, Z., Lopez, M., Ansari, M., Strunz, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2882-8 · Cited by 178
Yao, C., Liu, X., & Tang, Z. (2017) · International Journal of COPD · doi:10.2147/copd.s141760 · Cited by 167
Epithelial Barrier Dysfunction in Chronic Respiratory Diseases
Carlier, F. M., Fays, C. D., & Pilette, C. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.691227 · Cited by 181
Lung densitometry: why, how and when
Mascalchi, M., Camiciottoli, G., & Diciotti, S. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.08.17 · Cited by 165
Bousquet, J. J., Hellings, P. W., Agache, I. O., Amat, F., Annesi‐maesano, I., Ansotegui, I. J., Antó, J. M., Bachert, C., Bateman, E., Bedbrook, A., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.08.049 · Cited by 174
Bronchiectasis in COPD patients: more than a comorbidity?
Martínez‐García, M. Á., & Miravitlles, M. (2017) · International Journal of COPD · doi:10.2147/copd.s132961 · Cited by 162
Fan, X., Dong, T., Yan, K., Ci, X., & Peng, L. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102587 · Cited by 162
Ramón, M. A., ter Riet, G., Carsin, A., Gimeno‐Santos, E., Agustí, A. G. N., Antó, J. M., Donaire-González, D., Ferrer, J., Rodríguez, E., Rodriguez‐Roisin, R., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.00079-2018 · Cited by 174
Self-citationDumas, O., Varraso, R., Boggs, K. M., Quinot, C., Zock, J., Henneberger, P. K., Speizer, F. E., Moual, N. L., & Camargo, C. A. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.13563 · Cited by 173
Labaki, W. W., Martínez, C. H., Martínez, F. J., Galbán, C. J., Ross, B. D., Washko, G. R., Barr, R. G., Regan, E. A., Coxson, H. O., Hoffman, E. A., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201703-0451pp · Cited by 155
Brighton, L. J., Miller, S., Farquhar, M. C., Booth, S., Yi, D., Gao, W., Bajwah, S., Man, W. D., Higginson, I. J., & Maddocks, M. M. (2018) · Thorax · doi:10.1136/thoraxjnl-2018-211589 · Cited by 153
Telemonitoring in Chronic Obstructive Pulmonary Disease (CHROMED). A Randomized Clinical Trial
Walker, P. P., Pompilio, P. P., Zanaboni, P., Bergmo, T. S., Prikk, K., Malinovschi, A., Montserrat, J. M., Middlemass, J., Šonc, S., Munaro, G., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2404oc · Cited by 152
Alqahtani, J. S., Njoku, C. M., Bereznicki, B., Wimmer, B. C., Peterson, G. M., Kinsman, L., Aldabayan, Y. S., Alrajeh, A. M., Aldhahir, A. M., Mandal, S., et al. (2020) · European Respiratory Review · doi:10.1183/16000617.0166-2019 · Cited by 149
Risk factors of chronic obstructive pulmonary disease exacerbations
Hogea, P., Tudorache, E., Fildan, A. P., Firă-Mladinescu, O., Marc, M. S., & Oancea, C. I. (2019) · The Clinical Respiratory Journal · doi:10.1111/crj.13129 · Cited by 160
Liang, G.-B., & He, Z. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000469 · Cited by 144
Tan, D., Walline, J. H., Ling, B., Xu, Y., Sun, J., Wang, B., Shan, X., Wang, Y., Cao, P., Zhu, Q., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03214-9 · Cited by 154
Sargis, R. M., & Simmons, R. A. (2019) · Diabetologia · doi:10.1007/s00125-019-4940-z · Cited by 140
Phosphodiesterases as therapeutic targets for respiratory diseases
Zuo, H., Cattani‐Cavalieri, I., Musheshe, N., Nikolaev, V. O., & Schmidt, M. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.002 · Cited by 139
The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study
Adibi, A., Sin, D. D., Safari, A., JOHNSON, K., Aaron, S. D., FitzGerald, J. M., & Sadatsafavi, M. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30397-2 · Cited by 141
Self-citationOshagbemi, O. A., Burden, A. M., Braeken, D. C. W., Henskens, Y., Wouters, E. F. �., Driessen, J. H. M., der Zee, A. H. M., de Vries, F., & Franssen, F. M. E. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0009le · Cited by 136
Hosseini, M., Almasi‐Hashiani, A., Sepidarkish, M., & Maroufizadeh, S. (2019) · Respiratory Research · doi:10.1186/s12931-019-1198-4 · Cited by 140
Filho, F. S. L., Alotaibi, N. M., Ngan, D., Tam, S., Yang, J., Hollander, Z., Chen, V., FitzGerald, J. M., Nislow, C., Leung, J. M., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201806-1135oc · Cited by 140
Self-citationCriner, G. J., Eberhardt, R., Fernández-Bussy, S., Gompelmann, D., Maldonado, F., Patel, N. M., Shah, P. L., Slebos, D., Valipour, A., Wahidi, M. M., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201907-1292so · Cited by 138
Self-citationFedele, D., Francesco, A. D., Riso, S., & Collo, A. (2020) · Nutrition · doi:10.1016/j.nut.2020.111016 · Cited by 138
Volpato, E., Toniolo, S., Pagnini, F., & Banfi, P. I. (2021) · International Journal of COPD · doi:10.2147/copd.s313841 · Cited by 144
Sullivan, D. R., Iyer, A. S., Enguidanos, S. M., Cox, C. E., Farquhar, M. C., Janssen, D. J. A., Lindell, K. O., Mularski, R. A., Smallwood, N., Turnbull, A. E., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202207-1262st · Cited by 134
A portable triboelectric spirometer for wireless pulmonary function monitoring
Xu, Q., Fang, Y., Jing, Q., Hu, N., Lin, K., Pan, Y., Xu, L., Gao, H., Yuan, M., Chu, L., et al. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113329 · Cited by 133
the H. F.-AECOPD study investigators, Cortegiani, A., Longhini, F., Madotto, F., Groff, P., Scala, R., Crimi, C., Carlucci, A., Bruni, A., Garofalo, E., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03409-0 · Cited by 128
Human airway branch variation and chronic obstructive pulmonary disease
Smith, B. M., Traboulsi, H., Austin, J. H. M., Manichaikul, A. W., Hoffman, E. A., Bleecker, E. R., Cardoso, W. V., Cooper, C. S., Couper, D. J., Dashnaw, S. M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715564115 · Cited by 127
Polverino, F., Celli, B. R., & Owen, C. A. (2018) · Pulmonary Circulation · doi:10.1177/2045894018758528 · Cited by 127
Self-citationCui, W., Zhang, Z., Zhang, P., Qu, J., Zheng, C., Mo, X., Zhou, W., Xu, L., Yao, H., & Gao, J. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13628 · Cited by 128
Moll, M. R., Sakornsakolpat, P., Shrine, N. R. G., Hobbs, B. D., DeMeo, D. L., John, C., Guyatt, A. L., McGeachie, M. J., Gharib, S. A., Obeidat, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30101-6 · Cited by 130
Characterisation of lung macrophage subpopulations in COPD patients and controls
Dewhurst, J. A., Lea, S., Hardaker, E. L., Dungwa, J. V., Ravi, A., & Singh, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-07101-2 · Cited by 125
Self-citationLi, F., Xu, M., Wang, M., Wang, L., Wang, H., Zhang, H., Chen, Y., Gong, J., Zhang, J. J., Adcock, I. M., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0931-8 · Cited by 125
Nutritional status, dietary intake, and health-related quality of life in outpatients with COPD
Nguyen, H. T., Collins, P. F., Pavey, T., Nhung, N. V., Pham, T. D., & Gallegos, D. (2019) · International Journal of COPD · doi:10.2147/copd.s181322 · Cited by 125
Mahler, D. A. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201702-156ps · Cited by 124
Eosinophilia, Frequent Exacerbations, and Steroid Response in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Tetzlaff, K., Vogelmeier, C. F., Fabbri, L. M., MAGNUSSEN, H., Wouters, E. F. �., Mezzanotte, W. S., Disse, B. G., Finnigan, H., Asijee, G. M., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201612-2525le · Cited by 122
Self-citationTanner, L., & Single, A. (2019) · Journal of Innate Immunity · doi:10.1159/000502489 · Cited by 126
Jang, Y. O., Lee, S. H., Choi, J. J., Kim, D.-H., Choi, J.-M., Kang, M.-J., Oh, Y.-M., Park, Y.-J., Shin, Y., & Lee, S. W. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0469-y · Cited by 121
Randomised controlled trial of adjunctive inspiratory muscle training for patients with COPD
Charususin, N., Gosselink, R., Decramer, M., Demeyer, H., MCCONNELL, A. K., Saey, D., Maltais, F., Derom, E., Vermeersch, S., Heijdra, Y. F., et al. (2018) · Thorax · doi:10.1136/thoraxjnl-2017-211417 · Cited by 127
Self-citationMarchioni, A., Castaniere, I., Tonelli, R., Fantini, R., Fontana, M. S., Tabbì, L., Viani, A., Giaroni, F., Ruggieri, V., Cerri, S., et al. (2018) · Critical Care · doi:10.1186/s13054-018-2033-x · Cited by 123
Natural history and mechanisms of COPD
Lange, P., Ahmed, E., Lahmar, Z. M., Martínez, F. J., & BOURDIN, A. A. (2021) · Respirology · doi:10.1111/resp.14007 · Cited by 127
Gao, N., Xu, W., Ji, J., Yang, Y., Wang, S., Wang, J., Chen, X., Meng, S., Tian, X., & Xu, K. (2020) · Environmental Health · doi:10.1186/s12940-020-0568-1 · Cited by 115
Adipose Tissue Inflammation and Pulmonary Dysfunction in Obesity
Palma, G., Sorice, G. P., Genchi, V. A., Giordano, F., Caccioppoli, C., D’Oria, R., Marrano, N., Biondi, G., Giorgino, F., & Perrini, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137349 · Cited by 126
Zheng, Y., Zhu, J., Liu, Y., Lai, W., Lin, C., Qiu, K., Wu, J., & Yao, W. (2018) · BMJ · doi:10.1136/bmj.k4388 · Cited by 115
Reconsidering the Utility of Race-Specific Lung Function Prediction Equations
Baugh, A. D., Shiboski, S. C., Hansel, N. N., Ortega, V. E., Barjaktarević, I., Barr, R. G., Bowler, R. P., Comellas, A. P., Cooper, C. B., Couper, D. J., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202105-1246oc · Cited by 114
Self-citationHome High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD: A Randomized Clinical Trial
Nagata, K., Horie, T., Chohnabayashi, N., Jinta, T., Tsugitomi, R., Shiraki, A., Tokioka, F., Kadowaki, T., Watanabe, A., Fukui, M., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202201-0199oc · Cited by 128
Sigurgeirsdóttir, J., Halldórsdóttir, S., Arnardóttir, R. H., Guðmundsson, G., & Bjornsson, E. H. (2019) · International Journal of COPD · doi:10.2147/copd.s201068 · Cited by 134
Rehman, A. U., Hassali, M. A., Muhammad, S. A., Harun, S. N., Shah, S., & Abbas, S. (2019) · The European Journal of Health Economics · doi:10.1007/s10198-019-01119-1 · Cited by 114
Endoscopic Lung Volume Reduction: An Expert Panel Recommendation – Update 2019
Herth, F. J. F., Slebos, D., Criner, G. J., Valipour, A., Sciurba, F. C., & Shah, P. L. (2019) · Respiration · doi:10.1159/000496122 · Cited by 112
Self-citationTang, L. Y. W., Coxson, H. O., Lam, S. C., Leipsic, J. A., Tam, R. C., & Sin, D. D. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30064-9 · Cited by 111
Self-citationRodriguez‐Roisin, R., Rabe, K. F., Vestbo, J., Vogelmeier, C. F., & Agustí, A. G. N. (2017) · European Respiratory Journal · doi:10.1183/13993003.00671-2017 · Cited by 113
Self-citationGea, J., Sancho‐Muñoz, A., & Chalela, R. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.02.66 · Cited by 111
High-fiber diets attenuate emphysema development via modulation of gut microbiota and metabolism
Jang, Y. O., Kim, O., Kim, S. J., Lee, S. H., Yun, S., Lim, S. E., Yoo, H. J., Shin, Y. M., & Lee, S. W. (2021) · Scientific Reports · doi:10.1038/s41598-021-86404-x · Cited by 108
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function
Han, M. K., Ye, W., Wang, D., White, E., Arjomandi, M., Barjaktarević, I., Brown, S.-A. W., Buhr, R. G., Comellas, A. P., Cooper, C. B., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2204752 · Cited by 106
Self-citationNon-coding RNA-based regulation of inflammation
Ashrafizadeh, M., Zarrabi, A., Mostafavi, E., Aref, A. R., Sethi, G., Wang, L., & Tergaonkar, V. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101606 · Cited by 107
Sun, J., Li, Y., Ling, B., Zhu, Q., Hu, Y., Tan, D., Geng, P., & Xu, J. (2019) · International Journal of COPD · doi:10.2147/copd.s206567 · Cited by 110
Washio, Y., Sakata, S., Fukuyama, S., Honda, T., Kan‐o, K., Shibata, M., Hata, J., Inoue, H., Kitazono, T., Matsumoto, K., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202110-2302oc · Cited by 104
Metadata
- Authors
- Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., Frith, P., Halpin, D. M. G., López Varela, M. V., Nishimura, M., Roche, N., Rodriguez-Roisin, R., Sin, D. D., Singh, D., Stockley, R., Vestbo, J., Wedzicha, J. A., & Agustí, A.
- Affiliations
- Philipps University of Marburg (DE)
- Temple University (US)
- New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, New York
- The University of Texas at San Antonio Health Science Center (US)
- Imperial College London (GB)
- McGill University Health Centre (CA)
- Brigham and Women’s Hospital, Boston, Massachusetts
- First Affiliated Hospital of Guangzhou Medical University (CN)
- KU Leuven (BE)
- University of Modena and Reggio Emilia (IT)
- Flinders University (AU)
- Royal Devon and Exeter Hospital (GB)
- Universidad de la República, Hospital Maciel, Montevideo, Uruguay
- Hokkaido University (JP)
- Hôpital Cochin (Assistance Publique–Hôpitaux de Paris), University Paris Descartes, Paris, France
- Thorax Institute, Hospital Clinic Universitat de Barcelona, Barcelona, Spain
- University of British Columbia (CA)
- University Hospital, Birmingham, United Kingdom; and
- University of Manchester (GB)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- Corresponding author
- Vogelmeier, Claus F.
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-03-01
- Volume
- 195
- Issue
- 5
- Pages
- 557-582
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2583265473
- Cited by
- 3,187
- References
- 305
- Citations by year
- 2026: 118 · 2025: 162 · 2024: 247 · 2023: 307 · 2022: 415 · 2021: 441 · 2020: 449 · 2019: 436 · 2018: 428 · 2017: 173
- FWCI
- 336.54
- Type
- journal article
- Language
- en
- Open access
- green
- lirias.kuleuven.be
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0510-10270, NF-SI-0513-10077, NF-SI-0611-10148)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- chronic obstructive pulmonary disease, GOLD 2017, COPD diagnosis, COPD management, COPD prevention, exacerbations, non-pharmacological treatment, comorbidities, spirometry, symptom assessment
- MeSH terms
- Bronchodilator Agents, Humans, Risk Factors, Spirometry, Global Health, Pulmonary Disease, Chronic Obstructive, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
